Robert J. Gould, See Remarks at Fulcrum Therapeutics, Inc. (FULC), sold 10,000 shares at $12.08 ($121K) on 2021-01-20, disclosed to the SEC on 2021-01-22.
Open-market sale of $121k FULC by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FULC | SELL | 2026-01-06 | $356K | — | Filing → |
| FULC | SELL | 2025-11-21 | $165K | — | Filing → |
| FULC | SELL | 2023-01-13 | $101K | — | Filing → |